Your browser doesn't support javascript.
loading
Body mass index (BMI) does not predict responses to psilocybin.
Spriggs, Meg J; Giribaldi, Bruna; Lyons, Taylor; Rosas, Fernando E; Kärtner, Laura S; Buchborn, Tobias; Douglass, Hannah M; Roseman, Leor; Timmermann, Christopher; Erritzoe, David; Nutt, David J; Carhart-Harris, Robin L.
Afiliación
  • Spriggs MJ; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Giribaldi B; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Lyons T; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Rosas FE; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Kärtner LS; Centre for Complexity Science, Imperial College London, UK.
  • Buchborn T; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Douglass HM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Roseman L; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Timmermann C; Institute for Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
  • Erritzoe D; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Nutt DJ; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
  • Carhart-Harris RL; Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.
J Psychopharmacol ; 37(1): 107-116, 2023 01.
Article en En | MEDLINE | ID: mdl-36373934
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido